drugset / Trial / NCT04080895

Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects

NCT04080895

RandomizedCrossoverOpen-labelTreatment

Summary

This is an open-label pharmacokinetic study in 16 healthy Thai subjects. To assess the safety and tolerability and pharmacological interactions of the combination of artemether-lumefantrine and amodiaquine. This study is funded by Prof White's WT PRF. The Welcome Trust grant reference number is B9R04920.

Timeline

Start
2022-11-01
Primary completion
2025-04-01
Completion
2025-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Artemether-lumefantrine Unknown Oral
Subject amodiaquine Other / unclassified Oral

Indications

No indication recorded.